Aidoc is revolutionizing clinical decision-making with its advanced AI technology, aiming to assist physicians in making faster and more accurate clinical decisions. The company, co-founded by Michael Braginsky, recently secured $150 million in funding to accelerate its growth and broaden its disease coverage. Previously limited to addressing one disease every few months, Aidoc’s new technology promises to tackle dozens annually, paving the way for new medical discoveries and expanding medical knowledge. Despite concerns about AI replacing medical professionals, Braginsky emphasizes the synergy between AI and physicians, stating that their collaboration enhances decision-making rather than replacing human expertise.
How is Aidoc enhancing clinical AI for physicians?
